Pfizer Inc. (PFE)
25.28
-0.20
(-0.78%)
USD |
NYSE |
Jan 12, 16:00
25.30
+0.02
(+0.08%)
After-Hours: 19:51
Pfizer Free Cash Flow: 10.38B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Vertex Pharmaceuticals, Inc. | 3.337B |
| Viking Therapeutics, Inc. | -224.58M |
| Moderna, Inc. | -2.663B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.603B |
| Cash from Investing (Quarterly) | -2.43B |
| Cash from Financing (Quarterly) | -2.476B |
| Free Cash Flow Per Share (Quarterly) | 0.7002 |
| Free Cash Flow to Equity (Quarterly) | 4.086B |
| Free Cash Flow to Firm (Quarterly) | 4.695B |
| Free Cash Flow Yield | 7.19% |